AR011139A1 - 4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contiene - Google Patents
4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contieneInfo
- Publication number
- AR011139A1 AR011139A1 ARP980100621A ARP980100621A AR011139A1 AR 011139 A1 AR011139 A1 AR 011139A1 AR P980100621 A ARP980100621 A AR P980100621A AR P980100621 A ARP980100621 A AR P980100621A AR 011139 A1 AR011139 A1 AR 011139A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- preparation
- pharmaceutical composition
- aminoalcoxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/102—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or selection affected or controlled by the adaptive coding
- H04N19/124—Quantisation
- H04N19/126—Details of normalisation or weighting functions, e.g. normalisation matrices or variable uniform quantisers
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/134—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or criterion affecting or controlling the adaptive coding
- H04N19/154—Measured or subjectively estimated visual quality after decoding, e.g. measurement of distortion
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/169—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding
- H04N19/17—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding the unit being an image region, e.g. an object
- H04N19/172—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding the unit being an image region, e.g. an object the region being a picture, frame or field
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/169—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding
- H04N19/182—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the coding unit, i.e. the structural portion or semantic portion of the video signal being the object or the subject of the adaptive coding the unit being a pixel
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/60—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using transform coding
- H04N19/61—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using transform coding in combination with predictive coding
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/85—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using pre-processing or post-processing specially adapted for video compression
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/102—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or selection affected or controlled by the adaptive coding
- H04N19/124—Quantisation
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/102—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or selection affected or controlled by the adaptive coding
- H04N19/132—Sampling, masking or truncation of coding units, e.g. adaptive resampling, frame skipping, frame interpolation or high-frequency transform coefficient masking
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/134—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or criterion affecting or controlling the adaptive coding
- H04N19/146—Data rate or code amount at the encoder output
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/134—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or criterion affecting or controlling the adaptive coding
- H04N19/146—Data rate or code amount at the encoder output
- H04N19/149—Data rate or code amount at the encoder output by estimating the code amount by means of a model, e.g. mathematical model or statistical model
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/134—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or criterion affecting or controlling the adaptive coding
- H04N19/146—Data rate or code amount at the encoder output
- H04N19/15—Data rate or code amount at the encoder output by monitoring actual compressed data size at the memory before deciding storage at the transmission buffer
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/10—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding
- H04N19/134—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using adaptive coding characterised by the element, parameter or criterion affecting or controlling the adaptive coding
- H04N19/146—Data rate or code amount at the encoder output
- H04N19/152—Data rate or code amount at the encoder output by measuring the fullness of the transmission buffer
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
- H04N19/60—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals using transform coding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- Multimedia (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
4-aminodioxi-1,3-dihidro-benzoimidazol-2-tionas que comprenden la formula (I), en la cual: R1 es hidrogeno o alquilo C1-C6; R2 es hidrogeno o alquiloC1-C6; R3 es seleccionada entre hidrogeno, alquilo C1-C10 de cadena recta o ramificada con hasta 10 átomos de carbono, ciclohexilmetilo, 4-fluorobutirofenona, -(CH2)mAr, donde Ar es fenilo, naftalenilo, tienilo, furanilo o piridinilo, cada uno de ellos optativamente sustituido por uno o dossustituyentes seleccionados entre alquilo C1-C6, halogeno, alcoxi c1-C6, trifluorometilo; o NR2R3 es 1,2,3,4-tetrahidroquinolin-1-ilo o 1,2,3,4-tetrahidroisoquinolin-1-ilo; m = 1-5; n= 1 o 2; Y es hidrogeno, halogeno, alquilo C1-C6, y alcoxi C1-C6; o una sal farmacéuticamente aceptable del mismo,su uso en la preparacion de un medicamento y composicion farmacéutica que los contiene. Estos compuestos son agentes dopaminérgicos D2 utiles en eltratamiento de esquizofrenia, enfermedad de Parkinson, síndrome de Tourette y adiccion a drogas o alcohol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80265197A | 1997-02-18 | 1997-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011139A1 true AR011139A1 (es) | 2000-08-02 |
Family
ID=25184324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100621A AR011139A1 (es) | 1997-02-18 | 1998-02-11 | 4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contiene |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0964854A1 (es) |
JP (1) | JP2001511803A (es) |
KR (1) | KR20000071124A (es) |
CN (1) | CN1252061A (es) |
AR (1) | AR011139A1 (es) |
AU (1) | AU5915298A (es) |
BR (1) | BR9807840A (es) |
CA (1) | CA2278718A1 (es) |
HU (1) | HUP0001942A2 (es) |
IL (1) | IL131157A0 (es) |
WO (1) | WO1998035947A1 (es) |
ZA (1) | ZA981308B (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189473B1 (de) * | 1984-08-15 | 1992-05-27 | Schering Aktiengesellschaft | Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
ES2169102T3 (es) * | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
-
1998
- 1998-01-13 KR KR1019997007412A patent/KR20000071124A/ko not_active Application Discontinuation
- 1998-01-13 ZA ZA981308A patent/ZA981308B/xx unknown
- 1998-01-13 EP EP98902512A patent/EP0964854A1/en not_active Withdrawn
- 1998-01-13 AU AU59152/98A patent/AU5915298A/en not_active Abandoned
- 1998-01-13 IL IL13115798A patent/IL131157A0/xx unknown
- 1998-01-13 BR BR9807840-2A patent/BR9807840A/pt not_active Application Discontinuation
- 1998-01-13 CN CN98804120A patent/CN1252061A/zh active Pending
- 1998-01-13 HU HU0001942A patent/HUP0001942A2/hu unknown
- 1998-01-13 WO PCT/US1998/000612 patent/WO1998035947A1/en not_active Application Discontinuation
- 1998-01-13 JP JP53572698A patent/JP2001511803A/ja active Pending
- 1998-01-13 CA CA002278718A patent/CA2278718A1/en not_active Abandoned
- 1998-02-11 AR ARP980100621A patent/AR011139A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN1252061A (zh) | 2000-05-03 |
KR20000071124A (ko) | 2000-11-25 |
WO1998035947A1 (en) | 1998-08-20 |
HUP0001942A2 (hu) | 2000-11-28 |
IL131157A0 (en) | 2001-01-28 |
CA2278718A1 (en) | 1998-08-20 |
ZA981308B (en) | 1999-08-17 |
JP2001511803A (ja) | 2001-08-14 |
AU5915298A (en) | 1998-09-08 |
EP0964854A1 (en) | 1999-12-22 |
BR9807840A (pt) | 2000-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
KR970704435A (ko) | 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands) | |
AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
HUP0400365A2 (hu) | 3-Fluor-pirrolidinek, mint cukorbetegség elleni szerek és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE327977T1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
NO963053D0 (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
DK0975595T3 (da) | Kokainanaloger | |
AR056321A1 (es) | COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS | |
HUP0401638A2 (hu) | Daganatellenes hatású tiofén- és tiazolszulfonamid származékok, valamint ezeket tartalmazó gyógyászati készítmények | |
SE9903997D0 (sv) | New compounds | |
ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
HUP0004780A2 (hu) | Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében | |
ATE268174T1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
FR2680172B1 (fr) | Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique. | |
GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
GEP20063754B (en) | Quinoline Derivatives and Use Thereof as Antitumor Agents | |
AR011136A1 (es) | Compuesto derivado 4-aminoalcoxi-1h-benzoimidazoles, composicion farmaceutica que lo contiene y el uso del mismo para la fabricacion de unmedicamento | |
AR011139A1 (es) | 4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contiene | |
GEP20043225B (en) | 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
ATE307131T1 (de) | Phenanthrolin-7-onderivate und ihre therapeutische verwendung | |
AR011137A1 (es) | Derivados de 4-aminoetoxiindazol, su uso para la preparacion de un medicamento y composiciones farmaceuticas que los contienen |